Atomoxetine for the treatment of attention-deficit/hyperactivity disorder (ADHD) in children with ADHD and dyslexia
about
Cognitive enhancers for the treatment of ADHDChildren with Attention Deficit/Hyperactivity Disorder and Reading Disability: A Review of the Efficacy of Medication TreatmentsRethinking Intelligence Quotient Exclusion Criteria Practices in the Study of Attention Deficit Hyperactivity DisorderThe genetic association between ADHD symptoms and reading difficulties: the role of inattentiveness and IQ.Efficacy and safety of atomoxetine in the treatment of children and adolescents with attention deficit hyperactivity disorderAtomoxetine improved attention in children and adolescents with attention-deficit/hyperactivity disorder and dyslexia in a 16 week, acute, randomized, double-blind trialA review of the efficacy of atomoxetine in the treatment of attention-deficit hyperactivity disorder in children and adult patients with common comorbidities.Effect of Atomoxetine Treatment on Reading and Phonological Skills in Children with Dyslexia or Attention-Deficit/Hyperactivity Disorder and Comorbid Dyslexia in a Randomized, Placebo-Controlled Trial.The co-occurrence of reading disorder and ADHD: epidemiology, treatment, psychosocial impact, and economic burden.The efficacy of atomoxetine for the treatment of children and adolescents with attention-deficit/hyperactivity disorder: a comprehensive review of over a decade of clinical research.Atomoxetine treatment for children and adolescents with Attention-Deficit/Hyperactivity Disorder (ADHD): a comprehensive meta-analysis of outcomes on parent-rated core symptomatology.Differential long-term medication impact on executive function and delay aversion in ADHD.Comparing treatments for children with ADHD and word reading difficulties: A randomized clinical trial.Comparative study of OROS-MPH and atomoxetine on executive function improvement in ADHD: a randomized controlled trial.Comorbidity between attention deficit hyperactivity disorder and reading disabilities: Implications for assessment and treatment
P2860
Q22251235-3F96CE34-670C-4820-AF35-85E5F72B61E2Q26741594-FB05FF4C-9226-4314-9734-6D060AF49D7AQ26746006-54C0045E-D1E5-4230-843D-7EE388BD948DQ34242812-A47562F4-0121-4888-9FD2-E3736709E6C9Q36751226-9EDB9BD0-DF10-4937-BF55-603EDE5AE184Q37348512-7691EE92-DD5B-4123-8D84-728B16DC8FDFQ37638740-8C9DF5B3-760C-4E47-B6A4-F74C8F37DD8AQ37667652-00B4AB8B-53AB-42EE-B933-CA6CE6F25AAFQ37901249-672A9B5A-885C-4A2B-9C67-18379E7A2DCFQ38362252-5BF2CEE4-0797-4AAD-B064-93CA31FFB48FQ39097761-C1457D8A-BF18-461A-91C6-69F7CCB85476Q49821724-A0ECD12D-F971-4366-AE30-6852281C34AFQ50449370-551A1648-E427-46C6-B058-BAC664E67B05Q50782551-DC8917D3-3B58-41D0-93BF-0CEC6D289309Q57598467-511B9F88-2331-4D19-8F79-BBE83AA34B23
P2860
Atomoxetine for the treatment of attention-deficit/hyperactivity disorder (ADHD) in children with ADHD and dyslexia
description
2009 nî lūn-bûn
@nan
2009 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
name
Atomoxetine for the treatment ...... hildren with ADHD and dyslexia
@ast
Atomoxetine for the treatment ...... hildren with ADHD and dyslexia
@en
Atomoxetine for the treatment of attention-deficit/hyperactivity disorder
@nl
type
label
Atomoxetine for the treatment ...... hildren with ADHD and dyslexia
@ast
Atomoxetine for the treatment ...... hildren with ADHD and dyslexia
@en
Atomoxetine for the treatment of attention-deficit/hyperactivity disorder
@nl
prefLabel
Atomoxetine for the treatment ...... hildren with ADHD and dyslexia
@ast
Atomoxetine for the treatment ...... hildren with ADHD and dyslexia
@en
Atomoxetine for the treatment of attention-deficit/hyperactivity disorder
@nl
P2093
P2860
P921
P356
P1476
Atomoxetine for the treatment ...... hildren with ADHD and dyslexia
@en
P2093
Calvin R Sumner
David Williams
Linda Wietecha
Michael Greenbaum
Millie Hollandbeck
Richard Rubin
Susan Gathercole
P2860
P2888
P356
10.1186/1753-2000-3-40
P577
2009-12-15T00:00:00Z
P5875
P6179
1029632169